前往 Telmisartan, Ramipril, or Both in Patients at High Risk for ...
常見ONTARGET trial問答
shep trialaccomplish trialtranscend trialONTARGET trialontarget trial pdfontarget trial pptSPRINT trialTRANSCEND trialACCOMPLISH trialALTITUDE trialN engl j med 2000 342 145 153ONTARGET trial pptONTARGET trialONTARGET trial pdf
延伸文章資訊Clinical trials of angiotensin-converting enzyme (ACE) inhibitors and ... combination with Ramipr...
... in high-risk patients: results from ONTARGET and TRANSCEND trials ... The Systolic blood Pres...
The ONTARGET (Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial) ...
The ONTARGET Trial Programme includes the ONTARGET and TRANSCEND studies. In both studies, partic...
The 2008 Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARG...
... Alone and in combination with Ramipril Global Endpoint Trial - ONTARGET ... Trial Sponsor: Bo...
The Ongoing Telmisartan Alone and combination with Ramipril global Endpoint trial (ONTARGET). Tim...
Clinical trials of angiotensin-converting enzyme (ACE) inhibitors and ... combination with Ramipr...
... in high-risk patients: results from ONTARGET and TRANSCEND trials ... The Systolic blood Pres...
The ONTARGET (Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial) ...
The ONTARGET Trial Programme includes the ONTARGET and TRANSCEND studies. In both studies, partic...
The 2008 Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARG...
... Alone and in combination with Ramipril Global Endpoint Trial - ONTARGET ... Trial Sponsor: Bo...
The Ongoing Telmisartan Alone and combination with Ramipril global Endpoint trial (ONTARGET). Tim...